1.
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic : prospective cohort study protocol
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol
2.
3.
4.
5.
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium : a prospective cohort study with 12 months of follow-up
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign
6.
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 1 : februari 2021
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium in August 2021 : brief communication on preliminary results of the SCOPE study
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 2 : april 2021